Colostrum Stem Cells Neural Differentiation Antimicrobial
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating neurological disorders and preventing microbial infections in livestock rely heavily on antibiotics, which can lead to antibiotic resistance and other adverse effects.
Innovation Solution
Development of colostrum-derived stem cell populations capable of providing an antimicrobial effect, obtained from female mammals in an inflammatory state or cultured with inflammatory inducing agents, and induced to differentiate into neural cells using a neural progenitor medium.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional differentiation methods using growth factors and supplements are used, then neural cell differentiation can be achieved, but the process requires lengthy culture time and sophisticated culturing techniques
Solution Approach 1:
The patent changes the chemical composition parameters of the culture medium by incorporating colostrum-derived components (IGF-1, HGF, EGF, TGF-α) to accelerate the differentiation process. This parameter modification enables neural cell differentiation to occur in a shorter time frame while maintaining reliability, directly addressing the time loss issue without sacrificing differentiation capability.
2Reliability
If antibiotics are used to prevent microbial infections in livestock, then infection prevention is achieved, but antibiotic resistance develops and adverse effects occur
Solution Approach 1:
The patent introduces colostrum-derived stem cells as an intermediary agent that provides antimicrobial protection through natural immune factors (IGF-1, HGF, EGF, TGF-α) rather than using antibiotics directly. These stem cells act as mediators that prevent microbial infections while avoiding the harmful effects of antibiotic resistance, thus resolving the contradiction between effective infection prevention and avoidance of adverse effects.
3Productivity
If complex growth factor combinations are used for neural differentiation, then differentiation efficiency is improved, but device complexity and culturing sophistication increase
Solution Approach 1:
The patent merges multiple growth factors (IGF-1, HGF, EGF, TGF-α) that are naturally present in colostrum into a single integrated culture medium formulation. This consolidation approach maintains high differentiation efficiency while reducing the complexity of culturing techniques by providing a pre-formulated, all-in-one medium that eliminates the need for separate addition and management of individual growth factors.
Data Source
AI summary
The invention provides colostrum derived stem cell populations, compositions and supplements having antimicrobial properties for enhancing mammalian health and for treating or preventing microbial contamination or infection. Also provided are methods of producing these populations, compositions and supplements from a female mammal in an inflammatory state. Also provided are colostrum derived stem cell populations and method of inducing differentiation into neural cells in neural progenitor medium including mammalian cell culture medium supplemented with casein depleted fraction of whey derived from colostrum. Also provided are neural progenitor medium, population of in vitro differentiated neural cells and pharmaceutical compositions containing same for use in treating neurological disease or disorder.